Provided by Tiger Trade Technology Pte. Ltd.

Ashland

49.92
+1.112.27%
Post-market: 49.920.00000.00%16:10 EDT
Volume:835.91K
Turnover:42.02M
Market Cap:2.28B
PE:-3.30
High:51.05
Open:50.17
Low:49.90
Close:48.81
52wk High:65.65
52wk Low:45.21
Shares:45.76M
Float Shares:41.77M
Volume Ratio:0.95
T/O Rate:2.00%
Dividend:1.65
Dividend Rate:3.31%
EPS(TTM):-15.1257
EPS(LYR):-18.3696
ROE:-29.98%
ROA:2.09%
PB:1.22
PE(LYR):-2.72

Loading ...

Press Release: Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 03

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Dow Jones
·
Feb 28

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Feb 27

Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Feb 26

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

GlobeNewswire
·
Feb 24

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

GlobeNewswire
·
Feb 24

Ashland Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Feb 18

Ashland price target raised to $62 from $53 at Evercore ISI

TIPRANKS
·
Feb 18

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Feb 17

Ashland (ASH) Valuation Check After Mixed Returns And Modest Undervaluation Estimate

Simply Wall St.
·
Feb 12

Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

GlobeNewswire
·
Feb 11

Is Ashland’s Q1 Results, Buybacks And New Partnership Altering The Investment Case For Ashland (ASH)?

Simply Wall St.
·
Feb 10

EPA Approves Ashland's Agrimer Eco-Coat Polymer Seed Coating for Food and Non-Food Uses

Reuters
·
Feb 09

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant

GlobeNewswire
·
Feb 05

Ashland Inc. veröffentlicht Transkript zur Q1 2026 Earnings Call

Reuters
·
Feb 05

Ashland Is Maintained at Overweight by JP Morgan

Dow Jones
·
Feb 05

UBS Adjusts Price Target on Ashland to $73 From $70, Maintains Buy Rating

MT Newswires Live
·
Feb 04

Stock Track | Ashland Soars 5.09% in Early Trading on Analyst Price Target Hikes

Stock Track
·
Feb 04

Ashland price target lowered to $70 from $77 at JPMorgan

TIPRANKS
·
Feb 04

Ashland : Deutsche Bank Raises Target Price to $70 From $58

THOMSON REUTERS
·
Feb 04